Trial Profile

INFORM-2

Discontinued
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2010

At a glance

  • Drugs Danoprevir; Mericitabine; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms INFORM-2
  • Sponsors Roche
  • Most Recent Events

    • 19 Feb 2010 Status changed from planning to discontinued, according to a Pharmasset media release.
    • 19 Nov 2009 New trial record.
    • 03 Nov 2009 The projected initiation date for this trial is in the first quarter of 2010, according to information presented in a Pharmasset media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top